新生儿戒断评分系统和母亲新生儿戒断量表的心理测量评估。
Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.
作者信息
Jones Hendrée E, Seashore Carl, Johnson Elisabeth, Horton Evette, O'Grady Kevin E, Andringa Kim, Grossman Matthew R, Whalen Bonny, Holmes Alison Volpe
机构信息
UNC Horizons and Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Departments of Psychiatry and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
出版信息
Am J Addict. 2016 Aug;25(5):370-3. doi: 10.1111/ajad.12388. Epub 2016 Jun 11.
BACKGROUND AND OBJECTIVES
The present study examined the psychometric characteristics of the Neonatal Abstinence Scoring System (NASS; "Finnegan Scale") and the MOTHER NAS Scale (MNS).
METHODS
Secondary analysis of data from 131 neonates from the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a randomized trial in opioid-dependent pregnant women administered buprenorphine or methadone.
RESULTS
Both the NASS and MNS demonstrated poor psychometric properties, with internal consistency (Cronbach's αs) failing to exceed .62 at first administration, peak NAS score, and NAS treatment initiation.
CONCLUSIONS
Findings support the need for development of a NAS measure based on sound psychometric principles.
SCIENTIFIC SIGNIFICANCE
This study found that two frequently used measures of neonatal abstinence syndrome suffer inadequacies in regard to their basic measurement characteristics. (Am J Addict 2016;25:370-373).
背景与目的
本研究探讨了新生儿戒断评分系统（NASS；“芬尼根量表”）和母亲新生儿戒断量表（MNS）的心理测量学特征。
方法
对来自“母亲阿片类药物治疗：人体实验研究”（MOTHER）的131名新生儿的数据进行二次分析，该研究是一项针对阿片类药物依赖孕妇的随机试验，给予丁丙诺啡或美沙酮治疗。
结果
NASS和MNS均表现出较差的心理测量学特性，在首次给药、NAS评分峰值和NAS治疗开始时，内部一致性（克朗巴哈系数）均未超过0.62。
结论
研究结果支持基于合理心理测量学原则开发NAS测量方法的必要性。
科学意义
本研究发现，两种常用的新生儿戒断综合征测量方法在基本测量特征方面存在不足。（《美国成瘾杂志》2016年；25:370 - 373）
Zotero 插件